Research Snapshot: Drs. Joshua Wong & Leonardo Almeida
Pilot study led by UF neurologists showed that biphasic DBS was safe, well tolerated and may provide faster benefit for patients with primary dystonia.
Posted in
Chronic Neurological Diseases News
Huntington’s disease clinic renewed as a HDSA Center of Excellence
Normal Fixel Institute one of three in Florida and 56 nationwide to receive renewal.
Neuroscientists earn College of Medicine research awards
Drs. Coralie de Hemptinne and Barry Setlow received recognition for their research and mentorship accomplishments.
Using artificial intelligence and patient medical records to predict Alzheimer’s disease
Researchers designed an AI system that can predict which patients will develop Alzheimer’s up to five years before receiving a diagnosis.
Air pollution may create U.S. ‘hot spots’ for Parkinson’s risk
Dr. Michael Okun commented for HealthDay article about a new study looking into pollution’s impact on Parkinson’s diagnoses.
Neuro departments Top 5 overall in NIH funding
Neuromedicine and neuroscience research at UF ranked Top 5 among all universities (public and private) in the 2022 rankings of NIH funding.
North Central Florida Society for Neuroscience holds 13th annual conference
SfN conference included a 53-poster competition, a data blitz and a panel discussion on careers in science, academia and industry.
Clinical psychology doctoral students awarded prestigious NIH F31 fellowships
Lauren Kenney and Adrianna Ratajska are recipients of the Ruth L. Kirschstein Predoctoral Individual National Research Service Award.
Research Snapshot: Drs. Kara Johnson and Coralie de Hemptinne
UF study finds evoked resonant neural activity could serve as potential marker to guide DBS for Parkinson’s disease.
Medical community hopeful following FDA’s accelerated approval for Alzheimer’s disease treatment
Drs. Steven DeKosky and Glenn Smith discuss Lecanemab for WUFT article.
